Expanded data sources, new export integrations and advanced data preparation options provide unmatched usability and efficiency for even more use cases Datawatch Corporation (NASDAQ-CM: DWCH) ...
Results from MONARCH 3 show a numerical improvement in overall survival (OS) of 13.1 months for women with HR+, HER2- metastatic breast cancer treated with Verzenio plus an aromatase inhibitor in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results